SCHEMBL29892182

SCHEMBL29892182

Clc1cccc2c1c1ccccc1n2-c1ccccc1-c1cccc2c1sc1ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALOX5 P09917 1/20 0.41
▸ PARP14 Q460N5 1/20 0.39
▸ PRKDC P78527 7/20 0.36
▸ PIK3CD O00329 2/20 0.36
▸ PIK3CB P42338 2/20 0.36
▸ CCNC P24863 1/20 0.36
▸ CDK8 P49336 1/20 0.36
▸ TP53 P04637 2/20 0.35
▸ BRD4 O60885 1/20 0.34
▸ PIK3CA P42336 1/20 0.34
▸ MTOR P42345 1/20 0.34
▸ PIK3CG P48736 1/20 0.34
▸ KCNH2 Q12809 1/20 0.34
▸ BRDT Q58F21 1/20 0.34
▸ MAPK14 Q16539 2/20 0.33
▸ HTT P42858 1/20 0.33
▸ PAX8 Q06710 1/20 0.33
▸ MAPT P10636 2/20 0.32
▸ GPR3 P46089 1/20 0.32
▸ ADK P55263 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10029292 0.87 ALOX5 (0.49) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL22410584 0.85 ALOX5 (0.48) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL18505173 0.84 ATM (0.41) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL18561903 0.83 ALOX5 (0.40) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL18589627 0.82 ALOX5 (0.39) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL18505256 0.79 ALOX5 (0.37) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL22106926 0.79 ALOX5 (0.45) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26512536 0.79 ALOX5 (0.40) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL26049247 0.79 PARP14 (0.41) ALOX5PARP14PRKDCPIK3CDPIK3CB
SCHEMBL18962741 0.79 ALOX5 (0.48) ALOX5PARP14PRKDCPIK3CDPIK3CB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT TOSOH CORPORATION (JP) 2024-07-25 — — US disclosed
CN-117044428-A Lateral current suppressing material, carbazole compound, hole injection layer, and organic electroluminescent element 东曹株式会社 2023-11-10 — — CN disclosed
WO-2022211123-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE INJECTION LAYER, AND ORGANIC ELECTROLUMINESCENT ELEMENT 東ソー株式会社 2022-10-06 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240251665-A1 TRANSVERSE CURRENT SUPPRESSING MATERIAL, CARBAZOLE COMPOUND, HOLE-INJECTION LAYER AND ORGANIC ELECTROLUMINESCENT ELEMENT AXIN2, FZD7, SLC39A3 ALOX5 806/4885PARP14 4470/4885PRKDC 3383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback